Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.
Midline Lid
1 other identifier
observational
500
1 country
1
Brief Summary
This study will assess the efficacy, safety and practicality of using midline catheters for repeated intravenous lidocaine infusions in an outpatient pain management setting. Adult patients requiring serial lidocaine infusions for chronic pain will be enrolled and receive treatment through midline catheters over ten sessions. The study will investigate if the midline catheters are a safe and effective option for delivering repeated lidocaine infusions in the outpatient setting, offering a balance between ease of placement, acceptable complication risk and good patients' comfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2026
CompletedFirst Submitted
Initial submission to the registry
April 21, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
April 29, 2026
April 1, 2026
1.7 years
April 21, 2026
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful lidocaine infusion therapy without the need for additional venous access
Percentage of patients who received a daily lidocaine infusion for 10 days with a 2-day pause in an outpatient setting who did not require additional venous access.
12 days (from midline insertion to the end of the therapy)
Secondary Outcomes (8)
Midline Catheter Maintenance Duration
12 days (from midline insertion to the end of the therapy)
Number of Participants with Premature Catheter Removal and Reasons
12 days (from midline insertion to the end of the therapy)
A-DIVA scale score
The onset of therapy
Patient's satisfaction score
12 days (from midline insertion to the end of the therapy)
Number of catheter leakage events
12 days (from midline insertion to the end of the therapy)
- +3 more secondary outcomes
Study Arms (1)
Outpatient midline catheter
Patients who receive a midline catheter for lidocaine infusion daily for ten days with two days weekend pause.
Eligibility Criteria
Our study population is patients qualified for daily lidocaine infusion therapy for chronic pain. Patients are planned to receive an infusion daily for 10 days with 2 days weekend pause. The total therapy time is planned for 12 days.
You may qualify if:
- Patients qualified for lidocaine infusion therapy due to the chronic pain
- Able to provide consent
- ≥18 years of age
You may not qualify if:
- Lack of patient consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Szpital Kliniczny Dzieciątka Jezus
Warsaw, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2026
First Posted
April 29, 2026
Study Start
April 20, 2026
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
April 29, 2026
Record last verified: 2026-04